Clinical characteristics and risk factors associated with severe COVID-19: prospective analysis of 1,045 hospitalised cases in North-Eastern France, March 2020
Charlotte Kaeuffer(Université de Strasbourg), François Danion(Université de Strasbourg), Floriane Gallais(Inserm), Raphaël Clère-Jehl, Yves-Jean Zhu(Université de Strasbourg), Thibaut Fabacher(Université de Strasbourg), Yves Hansmann(Hôpitaux Universitaires de Strasbourg), O. Hinschberger(Centre Hospitalier de Mulhouse), Yvon Ruch(Hôpitaux Universitaires de Strasbourg), Valentin Pointurier(Groupe Hospitalier de la Région de Mulhouse et Sud Alsace), Benjamin Dervieux(Groupe Hospitalier de la Région de Mulhouse et Sud Alsace), Coralie Le Hyaric(Université de Strasbourg), Joy Mootien(Groupe Hospitalier de la Région de Mulhouse et Sud Alsace), Nicolás Meyer, Nicolas Lefèbvre(Université de Strasbourg), Valentin Greigert(Washington University in St. Louis), Loïc Kassègne, Antonin Hugerot(Université de Strasbourg)
Cited by 128
Related Papers
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
|The Lancet Infectious Diseases|2021|344
Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey
|Blood|2012|239
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection
|EBioMedicine|2021|239
Coagulase-Negative Staphylococci Pathogenomics
|International Journal of Molecular Sciences|2019|219
Coronavirus disease 2019 in pregnancy was associated with maternal morbidity and preterm birth
|American Journal of Obstetrics and Gynecology|2020|197